Medication info

Simvastatin 20 mg (Simvastatin)

Prescription medicationApproval withdrawn
Ingredient · strength
Simvastatin›Strength being verified
Manufacturer / importer
Cosmax Pharma Co., Ltd.
Appearance
Brownish-yellow oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Approval withdrawn

MFDS item code 201900690 · Approved 2019.01.29

This product's status changed to Approval withdrawn on 2023.07.19. It may no longer be sold, so consult a doctor or pharmacist before taking it.

Summary

Main use
Improvement of hyperlipidemia (including familial hypercholesterolemia in children); prevention of cardiovascular disease
Who uses it
Adults · Children
Adult dosage
Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose appropriately according to the initial LDL cholesterol level before starting treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if cholesterol levels fall below the target. Because of the increased risk of myopathy, including rhabdomyolysis, use of the 80 mg dose of this medicine, particularly during the first year of treatment, should be limited to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see ‘Warnings’). 2) For recommended doses in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, amlodipine, or nicotinic acid, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment), see below. (1) Administration to patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, patients with homozygous familial hypercholesterolemia should receive 40 mg of this medicine once daily in the evening. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not available. (2) In elderly patients, a daily dose of 20 mg of this medicine may achieve the maximum reduction in cholesterol levels. (3) Administration to patients receiving verapamil, diltiazem, or dronedarone When this medicine is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg per day. (4) Administration to patients receiving amiodarone, amlodipine, or ranolazine When this medicine is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg per day (see ‘Interactions’). (5) Concomitant administration with other lipid-lowering agents This medicine is effective when administered alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see ‘Do not administer to the following patients’) and fenofibrate), the dose of this medicine should not exceed 10 mg per day. Also, when this medicine is coadministered with lipid-lowering doses of nicotinic acid (1 g or more per day), the dose of this medicine should not exceed 20 mg per day (see ‘Interactions’). (6) Administration to patients with renal impairment Because this medicine is not extensively excreted by the kidneys, no dose adjustment is required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg per day and monitor carefully.
Children's dosage
Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the maximum recommended dose is 40 mg per day. Adjust the dose appropriately for each patient according to the recommended treatment goals. Allow an interval of 4 weeks or more between dose adjustments.

Ingredients

Manufacturer
Cosmax Pharma Co., Ltd.

Efficacy & effects

Improvement of hyperlipidemia (including familial hypercholesterolemia in children); prevention of cardiovascular disease

  • Coronary heart disease
  • diabetes
  • peripheral vascular disease
  • stroke
  • hypercholesterolemia
  • dyslipidemia
  • hypertriglyceridemia
  • heterozygous familial hypercholesterolemia
View approved original text

This medication is used to reduce the risk of cardiovascular diseases. It lowers the risk of death from heart disease, myocardial infarction, and occurrence of stroke in adult patients with a history of coronary heart disease, diabetes, peripheral vascular disease, or stroke, and reduces the related risks of vascular interventions. It also helps patients with hyperlipidemia to lower total cholesterol, LDL-cholesterol, apolipoprotein-B, and triglyceride levels, while increasing HDL-cholesterol levels. It is particularly used alongside diet in patients with familial hypercholesterolemia or mixed dyslipidemia. Additionally, it is used as an adjunct to diet to improve blood lipid levels in young patients with heterozygous familial hypercholesterolemia who meet specific criteria. It is effective for a wide range of cardiovascular diseases and dyslipidemia.

Dosage and Administration

Adult dosage

Patients must follow a standard cholesterol-lowering diet before and during treatment with this medicine. 1. Reduction of cardiovascular risk Adult patients at high risk of coronary heart disease events due to a history of coronary heart disease, diabetes, peripheral vascular disease, stroke, or other cerebrovascular disease The recommended initial dose is 40 mg of simvastatin once daily. 2. Hyperlipidemia 1) Reduction of risk in patients with hypercholesterolemia and coronary heart disease, and hyperlipidemia The usual recommended initial dose is 20 mg of this medicine once daily in the evening. Patients with mild to moderate hypercholesterolemia may start with 10 mg of this medicine. A dose of 5 ~ 40 mg of this medicine once daily in the evening is recommended. Adjust the dose appropriately according to the initial LDL cholesterol level before starting treatment, the treatment goal, and the patient's response to the medicine. Measure cholesterol levels 4 weeks after starting treatment and periodically thereafter to adjust the dose. Reduce the dose if cholesterol levels fall below the target. Because of the increased risk of myopathy, including rhabdomyolysis, use of the 80 mg dose of this medicine, particularly during the first year of treatment, should be limited to patients who have taken 80 mg of this medicine for 12 months or longer without evidence of muscle toxicity (see ‘Warnings’). 2) For recommended doses in patients receiving this medicine concomitantly with fibrates (excluding gemfibrozil and fenofibrate), amiodarone, verapamil, diltiazem, amlodipine, or nicotinic acid, and in specific patient groups (i.e., patients with homozygous familial hypercholesterolemia, elderly patients, and patients with renal impairment), see below. (1) Administration to patients with homozygous familial hypercholesterolemia Based on the results of controlled clinical trials, patients with homozygous familial hypercholesterolemia should receive 40 mg of this medicine once daily in the evening. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not available. (2) In elderly patients, a daily dose of 20 mg of this medicine may achieve the maximum reduction in cholesterol levels. (3) Administration to patients receiving verapamil, diltiazem, or dronedarone When this medicine is coadministered with verapamil, diltiazem, or dronedarone, the dose of this medicine should not exceed 10 mg per day. (4) Administration to patients receiving amiodarone, amlodipine, or ranolazine When this medicine is coadministered with amiodarone, amlodipine, or ranolazine, the dose of this medicine should not exceed 20 mg per day (see ‘Interactions’). (5) Concomitant administration with other lipid-lowering agents This medicine is effective when administered alone or in combination with a bile acid sequestrant. When this medicine is coadministered with a fibrate (excluding gemfibrozil (see ‘Do not administer to the following patients’) and fenofibrate), the dose of this medicine should not exceed 10 mg per day. Also, when this medicine is coadministered with lipid-lowering doses of nicotinic acid (1 g or more per day), the dose of this medicine should not exceed 20 mg per day (see ‘Interactions’). (6) Administration to patients with renal impairment Because this medicine is not extensively excreted by the kidneys, no dose adjustment is required in patients with mild to moderate renal impairment. However, in patients with severe renal impairment, start with an initial dose of 5 mg per day and monitor carefully.

Children's dosage

Pediatric patients aged 10 ~ 17 years with heterozygous familial hypercholesterolemia: The recommended initial dose is 10 mg of this medicine once daily in the evening. The recommended dose range is 10 ~ 40 mg per day, and the maximum recommended dose is 40 mg per day. Adjust the dose appropriately for each patient according to the recommended treatment goals. Allow an interval of 4 weeks or more between dose adjustments.

Precautions

This medication is primarily used to lower blood cholesterol levels and works in the liver to inhibit cholesterol synthesis. Caution is necessary when taking this medication, as serious muscle-related side effects such as myopathy or rhabdomyolysis may occur. The risk is particularly higher at high doses (80 mg), and if symptoms like muscle pain or weakness occur, you should inform your doctor immediately. It may affect liver function; therefore, patients with liver disease or abnormally elevated liver enzyme levels should not take this medication. Regular liver function tests before and during treatment are important. Women who are pregnant or may become pregnant and those who are breastfeeding should not take this medication and should consult a doctor and use contraception if pregnancy is planned. This medication may interact with certain drugs. Particularly, when taken with strong CYP3A4 inhibitors, gemfibrozil, cyclosporine, danazol, certain calcium channel blockers, or amiodarone, the risk of myopathy increases, so concurrent use or dosage adjustments may be necessary. Elderly patients, women, patients with hypothyroidism, and patients with poor kidney function may be at higher risk for myopathy and should exercise extra caution while taking this medication. This medication may rarely cause side effects such as hepatitis, liver dysfunction, peripheral neuropathy, thrombocytopenia, hypersensitivity reactions, or interstitial lung disease, so you should consult a doctor immediately if any abnormal symptoms arise. During treatment, avoid consuming large amounts of grapefruit juice, and inform any other doctor who prescribes new medications that you are taking this medication. In case of overdose, standard emergency measures should be taken, and it should be kept out of reach of children.

Side effects

  • Myopathy
  • rhabdomyolysis
  • abdominal pain
  • weakness
  • constipation
  • diarrhea
  • dyspepsia
  • bloating
  • nausea
  • headache
Show 90 more
  • upper respiratory infection
  • edema
  • atrial fibrillation
  • gastritis
  • diabetes mellitus
  • myalgia
  • insomnia
  • dizziness
  • bronchitis
  • sinusitis
  • eczema
  • urinary tract infection
  • muscle cramps
  • arthralgia
  • dysgeusia
  • extraocular movement disorders
  • facial paresis
  • tremors
  • sensory disturbances
  • peripheral neuropathy
  • peripheral nerve palsy
  • mental disorders
  • anxiety
  • sleep disorders
  • nightmares
  • depression
  • cognitive impairment
  • interstitial lung disease
  • anaphylaxis
  • angioedema
  • lupus erythematosus-like syndrome
  • polymyositis
  • dermatomyositis
  • vasculitis
  • purpura
  • thrombocytopenia
  • leukopenia
  • hemolytic anemia
  • positive antinuclear antibodies
  • increased erythrocyte sedimentation rate
  • eosinophilia
  • arthritis
  • urticaria
  • photophobia
  • fever
  • chills
  • flushing
  • fatigue
  • dyspnea
  • toxic epidermal necrolysis
  • mucous membrane syndrome
  • erythema multiforme
  • pancreatitis
  • hepatitis
  • liver failure
  • cholecystatic jaundice
  • hepatic steatosis
  • cirrhosis
  • fulminant hepatic necrosis
  • hepatocellular carcinoma
  • anorexia
  • vomiting
  • alopecia
  • pruritus
  • skin changes
  • gynecomastia
  • decreased libido
  • sexual dysfunction
  • cataract progression
  • ophthalmoplegia
  • anemia
  • elevated aminotransferases
  • elevated alkaline phosphatase
  • elevated gamma-GTP
  • increased bilirubin levels
  • thyroid function abnormalities
  • elevated serum creatine kinase
  • liver function test abnormalities
  • increased HbA1c
  • elevated fasting blood glucose levels
  • limb sensory numbness
  • tingling
  • cold sensation
  • muscle weakness
  • thrombocytopenia
  • dyspnea
  • non-productive cough
  • fatigue
  • weight loss
  • fever

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to prevent air or moisture from entering, and it is recommended to be stored at room temperature between 1 degree and 30 degrees Celsius. This method of storage will maintain the drug's effectiveness and prevent degradation.

Appearance and packaging

Appearance

Brownish-yellow oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.